|
US5077044A
(en)
|
1980-05-19 |
1991-12-31 |
The Board Of Trustees Of The Leland Stanford Jr. University |
Novel non-reverting shigella live vaccines
|
|
US4554101A
(en)
|
1981-01-09 |
1985-11-19 |
New York Blood Center, Inc. |
Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
|
|
US5174993A
(en)
|
1981-12-24 |
1992-12-29 |
Health Research Inc. |
Recombinant avipox virus and immunological use thereof
|
|
US5338683A
(en)
|
1981-12-24 |
1994-08-16 |
Health Research Incorporated |
Vaccinia virus containing DNA sequences encoding herpesvirus glycoproteins
|
|
US5110587A
(en)
|
1981-12-24 |
1992-05-05 |
Health Research, Incorporated |
Immunogenic composition comprising synthetically modified vaccinia virus
|
|
US4722848A
(en)
|
1982-12-08 |
1988-02-02 |
Health Research, Incorporated |
Method for immunizing animals with synthetically modified vaccinia virus
|
|
US4510245A
(en)
|
1982-11-18 |
1985-04-09 |
Chiron Corporation |
Adenovirus promoter system
|
|
ZA858044B
(en)
|
1984-11-01 |
1987-05-27 |
American Home Prod |
Oral vaccines
|
|
US5643579A
(en)
|
1984-11-01 |
1997-07-01 |
American Home Products Corporation |
Oral vaccines
|
|
US5036006A
(en)
|
1984-11-13 |
1991-07-30 |
Cornell Research Foundation, Inc. |
Method for transporting substances into living cells and tissues and apparatus therefor
|
|
US4945050A
(en)
|
1984-11-13 |
1990-07-31 |
Cornell Research Foundation, Inc. |
Method for transporting substances into living cells and tissues and apparatus therefor
|
|
US4797368A
(en)
|
1985-03-15 |
1989-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adeno-associated virus as eukaryotic expression vector
|
|
GB8508845D0
(en)
|
1985-04-04 |
1985-05-09 |
Hoffmann La Roche |
Vaccinia dna
|
|
US5223424A
(en)
|
1985-09-06 |
1993-06-29 |
Prutech Research And Development |
Attenuated herpesviruses and herpesviruses which include foreign DNA encoding an amino acid sequence
|
|
US4790987A
(en)
|
1985-11-15 |
1988-12-13 |
Research Corporation |
Viral glycoprotein subunit vaccine
|
|
US5310668A
(en)
|
1986-06-20 |
1994-05-10 |
Merck & Co., Inc. |
Varicella-zoster virus as a live recombinant vaccine
|
|
US5242829A
(en)
|
1986-09-23 |
1993-09-07 |
Therion Biologics Corporation |
Recombinant pseudorabies virus
|
|
IL86583A0
(en)
|
1987-06-04 |
1988-11-15 |
Molecular Eng Ass |
Vaccine containing a derivative of a microbe and method for the production thereof
|
|
US5294441A
(en)
|
1987-06-04 |
1994-03-15 |
Washington University |
Avirulent microbes and uses therefor: salmonella typhi
|
|
US5387744A
(en)
|
1987-06-04 |
1995-02-07 |
Washington University |
Avirulent microbes and uses therefor: Salmonella typhi
|
|
US5112749A
(en)
|
1987-10-02 |
1992-05-12 |
Praxis Biologics, Inc. |
Vaccines for the malaria circumsporozoite protein
|
|
US5225336A
(en)
|
1989-03-08 |
1993-07-06 |
Health Research Incorporated |
Recombinant poxvirus host range selection system
|
|
JP3044062B2
(ja)
|
1989-03-08 |
2000-05-22 |
ヘルス・リサーチ・インク |
組換えポックスウイルス宿主選択系
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
US5591439A
(en)
|
1989-03-24 |
1997-01-07 |
The Wistar Institute Of Anatomy And Biology |
Recombinant cytomegalovirus vaccine
|
|
EP0465560B1
(en)
|
1989-03-31 |
1996-06-05 |
Washington University |
VACCINES CONTAINING AVIRULENT phoP-TYPE MICROORGANISMS
|
|
EP0431668B1
(en)
|
1989-12-04 |
1995-02-15 |
Akzo Nobel N.V. |
Recombinant herpesvirus of turkeys and live vector vaccines derived thereof
|
|
US5294548A
(en)
|
1990-04-02 |
1994-03-15 |
American Biogenetic Sciences, Inc |
Recombianant Hepatitis a virus
|
|
WO1991018088A1
(en)
|
1990-05-23 |
1991-11-28 |
The United States Of America, Represented By The Secretary, United States Department Of Commerce |
Adeno-associated virus (aav)-based eucaryotic vectors
|
|
US5462734A
(en)
|
1990-11-02 |
1995-10-31 |
Wisconsin Alumni Research Foundation |
Bovine herpesvirus vaccine and method of using same
|
|
US5240703A
(en)
|
1991-03-01 |
1993-08-31 |
Syntro Corporation |
Attenuated, genetically-engineered pseudorabies virus s-prv-155 and uses thereof
|
|
US6034298A
(en)
|
1991-08-26 |
2000-03-07 |
Prodigene, Inc. |
Vaccines expressed in plants
|
|
US5955088A
(en)
|
1992-02-03 |
1999-09-21 |
Cedars-Sinai Medical Center |
Pharmaceutical compsition of herpes simplex virus type-1 (HSV-1), glycoproteins
|
|
EP0646178A1
(en)
|
1992-06-04 |
1995-04-05 |
The Regents Of The University Of California |
expression cassette with regularoty regions functional in the mammmlian host
|
|
US5273525A
(en)
|
1992-08-13 |
1993-12-28 |
Btx Inc. |
Injection and electroporation apparatus for drug and gene delivery
|
|
US5981505A
(en)
|
1993-01-26 |
1999-11-09 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for delivery of genetic material
|
|
US5593972A
(en)
|
1993-01-26 |
1997-01-14 |
The Wistar Institute |
Genetic immunization
|
|
AU675702B2
(en)
|
1993-01-26 |
1997-02-13 |
Leslie R. Coney |
Compositions and methods for delivery of genetic material
|
|
EP0708659A4
(en)
|
1993-06-07 |
2000-08-23 |
Genentech Inc |
HIV ENVELOPE POLYPEPTIDES
|
|
US5407073A
(en)
|
1993-10-01 |
1995-04-18 |
Toyo Chemical Co., Ltd. |
Floppy disk container
|
|
US5739118A
(en)
|
1994-04-01 |
1998-04-14 |
Apollon, Inc. |
Compositions and methods for delivery of genetic material
|
|
US6156319A
(en)
|
1994-07-25 |
2000-12-05 |
The Trustees Of The University Of Pennsylvania |
Soluble herpesvirus glycoprotein complex vaccine
|
|
NL9401820A
(nl)
|
1994-11-02 |
1996-06-03 |
Meyn Maschf |
Inrichting voor het bewerken van aan zijn poten opgehangen gevogelte.
|
|
US5962428A
(en)
|
1995-03-30 |
1999-10-05 |
Apollon, Inc. |
Compositions and methods for delivery of genetic material
|
|
US5650309A
(en)
|
1995-05-16 |
1997-07-22 |
The Regents Of The University Of California |
Viral vectors
|
|
US5698202A
(en)
|
1995-06-05 |
1997-12-16 |
The Wistar Institute Of Anatomy & Biology |
Replication-defective adenovirus human type 5 recombinant as a rabies vaccine carrier
|
|
EP2298900A1
(en)
*
|
1996-09-17 |
2011-03-23 |
Novartis Vaccines and Diagnostics, Inc. |
Compositions and methods for treating intracellular diseases
|
|
US6261281B1
(en)
|
1997-04-03 |
2001-07-17 |
Electrofect As |
Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells
|
|
JP2001520537A
(ja)
|
1997-04-03 |
2001-10-30 |
エレクトロフェクト・アクティーゼルスカブ |
医薬品と核酸の骨格筋への導入方法
|
|
HUP0004589A3
(en)
|
1997-06-30 |
2003-08-28 |
Centre Nat Rech Scient |
Improved method for transferring nucleic acid into the striped muscle and combination therefor
|
|
EP1100579B1
(en)
|
1998-07-13 |
2015-09-02 |
Inovio Pharmaceuticals, Inc. |
Skin and muscle-targeted gene therapy by pulsed electrical field
|
|
US6589529B1
(en)
|
1998-10-30 |
2003-07-08 |
Children's Hospital Medical Center |
Rotavirus subunit vaccine
|
|
CA2349505A1
(en)
*
|
1998-11-05 |
2000-05-11 |
Powderject Vaccines, Inc. |
Nucleic acid constructs for genetic immunization
|
|
US6740323B1
(en)
|
1999-11-24 |
2004-05-25 |
Chiron Corporation |
HBV/HCV virus-like particle
|
|
CA2407897A1
(en)
|
2000-05-05 |
2001-11-15 |
Cytos Biotechnology Ag |
Molecular antigen arrays and vaccines
|
|
US20030138769A1
(en)
|
2000-08-16 |
2003-07-24 |
Birkett Ashley J. |
Immunogenic HBc chimer particles having enhanced stability
|
|
JP3543326B2
(ja)
|
2001-08-30 |
2004-07-14 |
ソニー株式会社 |
情報処理装置および方法、情報処理システム、情報配信装置、記録媒体、並びにプログラム
|
|
AU2002339224B2
(en)
*
|
2001-09-14 |
2008-10-09 |
Kuros Us Llc |
Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
|
|
US7045319B2
(en)
|
2001-10-30 |
2006-05-16 |
Ribomed Biotechnologies, Inc. |
Molecular detection systems utilizing reiterative oligonucleotide synthesis
|
|
US7351413B2
(en)
*
|
2002-02-21 |
2008-04-01 |
Lorantis, Limited |
Stabilized HBc chimer particles as immunogens for chronic hepatitis
|
|
US8209006B2
(en)
|
2002-03-07 |
2012-06-26 |
Vgx Pharmaceuticals, Inc. |
Constant current electroporation device and methods of use
|
|
US7245963B2
(en)
|
2002-03-07 |
2007-07-17 |
Advisys, Inc. |
Electrode assembly for constant-current electroporation and use
|
|
WO2003082327A2
(en)
*
|
2002-03-28 |
2003-10-09 |
Brenntag Biosector A/S |
Combined dna/protein vaccine compositions
|
|
US7328064B2
(en)
|
2002-07-04 |
2008-02-05 |
Inovio As |
Electroporation device and injection apparatus
|
|
CN100381463C
(zh)
|
2002-09-18 |
2008-04-16 |
中国人民解放军免疫学研究所 |
用于生产治疗用乙型肝炎疫苗或药物的免疫原及其制备方法和用途
|
|
CA2504593C
(en)
|
2002-11-04 |
2016-08-09 |
Advisys, Inc. |
Synthetic muscle promoters with activities exceeding naturally occurring regulatory sequences in cardiac cells
|
|
EP1628749B1
(en)
|
2003-05-30 |
2019-07-31 |
VGXI, Inc. |
Devices and methods for biomaterial production
|
|
NZ570709A
(en)
*
|
2003-06-13 |
2010-04-30 |
Univ Pennsylvania |
Nucleic acid sequences encoding and compositions comprising IgE signal peptide and/or IL-15 and methods for using the same
|
|
WO2005023293A1
(en)
|
2003-09-09 |
2005-03-17 |
Pohang University Of Science And Technology |
Vaccine composition comprising il-12 adjuvant encapsulated in controlled-release microsphere
|
|
US20060024670A1
(en)
|
2004-05-18 |
2006-02-02 |
Luke Catherine J |
Influenza virus vaccine composition and methods of use
|
|
WO2006033679A2
(en)
|
2004-05-25 |
2006-03-30 |
Chimeracore, Inc. |
Self-assembling nanoparticle drug delivery system
|
|
WO2008089144A2
(en)
|
2007-01-12 |
2008-07-24 |
The Government Of The United States, As Represented By The Secretary Of Health And Human Services |
Improved dna vaccination protocols
|
|
KR100836745B1
(ko)
|
2007-01-31 |
2008-06-10 |
(주)두비엘 |
Ｈｂｖ 백신 및 그의 제조 방법
|
|
WO2008103380A2
(en)
|
2007-02-21 |
2008-08-28 |
Fox Chase Cancer Center |
Hepatitis b virus compositions and methods of use
|
|
EP2153260B1
(en)
|
2007-05-23 |
2017-01-25 |
VGXI, Inc. |
Composition comprising high concentration of biologically active molecules and processes for preparing the same
|
|
US20090214593A1
(en)
*
|
2007-08-16 |
2009-08-27 |
Tripep Ab |
Immunogen platform
|
|
US8138318B2
(en)
|
2007-09-13 |
2012-03-20 |
Abbott Laboratories |
Hepatitis B pre-S2 nucleic acid
|
|
EP2217064A4
(en)
*
|
2007-11-12 |
2012-10-03 |
Univ Pennsylvania |
NEW VACCINES FOR FIGHT AGAINST SEVERAL SUBTYPES OF INFLUENZA VIRUSES
|
|
ES2685435T3
(es)
|
2008-01-11 |
2018-10-09 |
Inovio Pharmaceuticals, Inc. |
Nuevas vacunas frente a múltiples subtipos del virus del dengue
|
|
KR101589511B1
(ko)
*
|
2008-04-04 |
2016-02-01 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
치쿤구니야 바이러스 단백질의 공통 서열, 이를 인코딩하는 핵산 분자, 조성물 및 이를 이용하는 방법
|
|
WO2010016071A2
(en)
|
2008-08-05 |
2010-02-11 |
Swati Subodh |
Identification of genomic signature for differentiating highly similar sequence variants of an organism
|
|
WO2010042751A2
(en)
*
|
2008-10-08 |
2010-04-15 |
Chimeros Inc. |
Chimeric therapeutics, compositions, and methods for using same
|
|
US8829174B2
(en)
|
2008-10-29 |
2014-09-09 |
The Trustees Of The University Of Pennsylvania |
HCV vaccines and methods for using the same
|
|
CN102292345B
(zh)
*
|
2008-11-17 |
2015-12-02 |
Vgx药品有限责任公司 |
引起对抗黄病毒的免疫应答的抗原及其应用方法
|
|
CN101502650B
(zh)
|
2009-03-10 |
2011-12-28 |
邢益平 |
密码子优化的乙型肝炎核酸疫苗
|
|
WO2010127115A1
(en)
|
2009-04-30 |
2010-11-04 |
Centre Hospitalier Universitaire Vaudois Lausanne (Chuv) |
Modified immunization vectors
|
|
US8298820B2
(en)
|
2010-01-26 |
2012-10-30 |
The Trustees Of The University Of Pennsylvania |
Influenza nucleic acid molecules and vaccines made therefrom
|
|
US9238679B2
(en)
*
|
2011-02-11 |
2016-01-19 |
The Trustees Of The University Of Pennslyvania |
Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same
|
|
CN103442732B
(zh)
|
2011-02-11 |
2017-04-12 |
宾夕法尼亚大学托管会 |
编码乙型肝炎病毒核心蛋白的核酸分子和包含其的疫苗
|
|
EA028659B1
(ru)
|
2011-02-12 |
2017-12-29 |
Глоубиммьюн, Инк. |
Терапевтическое средство на основе дрожжей для лечения хронического гепатита b
|
|
EP3288245B1
(en)
|
2016-08-16 |
2019-03-06 |
Guangdong Oppo Mobile Telecommunications Corp., Ltd. |
Fingerprint sensor and terminal using the same
|